Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Assets
Current assets:
Cash
Marketable securities
Accounts receivable, net of allowance
Other current assets
Total current assets
Property and equipment, net
Investments - warrants
Investments - Stock
Investments - Private
Investments - Collectibles
Investments - Real Estate
Due from related party
Intangible assets, net
Other assets
Total assets
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable
Due to related party
Accrued liabilities
Deferred revenue
Total current liabilities
Total liabilities
Stockholders' equity:
Preferred stock value
Series A Preferred Stock
Series T Preferred Stock
Series Seed Preferred Stock
Common stock, par value $0.00001, 1,580,000,000 shares authorized, 758,349,621 and 745,825,392 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively.
Additional paid-in capital
Noncontrolling interest
Accumulated deficit
Total stockholders' equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support